153 related articles for article (PubMed ID: 34244472)
1. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
[TBL] [Abstract][Full Text] [Related]
3. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
Zhu D; Huang J; Liu N; Li W; Yan L
Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
[TBL] [Abstract][Full Text] [Related]
4. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
[TBL] [Abstract][Full Text] [Related]
6. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
7. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
Li GW; Yan X
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
[TBL] [Abstract][Full Text] [Related]
8. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
Su J; Hu S; Ding S; Feng K
Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
[TBL] [Abstract][Full Text] [Related]
9. PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.
Zheng X; Wang Y; Wang D; Wan J; Qin X; Mu Z; Hu N
World J Surg Oncol; 2022 Mar; 20(1):84. PubMed ID: 35287689
[TBL] [Abstract][Full Text] [Related]
10. PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway.
Wang Y; Zhang S; Zhao Z; Jin Q; Wang Z; Song Z; Liu L; Zhao Z
Immunobiology; 2024 May; 229(3):152802. PubMed ID: 38569452
[TBL] [Abstract][Full Text] [Related]
11. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma.
Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ
Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933
[TBL] [Abstract][Full Text] [Related]
12. Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo.
Zhou B; Peng K; Wang G; Chen W; Kang Y
Calcif Tissue Int; 2021 Jul; 109(1):44-54. PubMed ID: 33625534
[TBL] [Abstract][Full Text] [Related]
13. Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration.
Chen Q; Fu L; Hu J; Guo G; Xie A
Cancer Cell Int; 2021 Apr; 21(1):235. PubMed ID: 33902600
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
15. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p.
Rong D; Lu C; Zhang B; Fu K; Zhao S; Tang W; Cao H
Mol Cancer; 2019 Feb; 18(1):25. PubMed ID: 30777076
[TBL] [Abstract][Full Text] [Related]
16. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma.
Yang Y; Qi F; Wei C; Liu J; Zhang Y; Luan W; Gu J
Cell Death Discov; 2021 Oct; 7(1):323. PubMed ID: 34716318
[TBL] [Abstract][Full Text] [Related]
17. PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma.
Duan X; Li H; Wang M; Ju S; Li F; Chen P; Lu H; Han X; Ren J
Cell Death Discov; 2021 Aug; 7(1):217. PubMed ID: 34413286
[TBL] [Abstract][Full Text] [Related]
18. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
19. Cancer vulnerabilities unveiled by genomic loss.
Nijhawan D; Zack TI; Ren Y; Strickland MR; Lamothe R; Schumacher SE; Tsherniak A; Besche HC; Rosenbluh J; Shehata S; Cowley GS; Weir BA; Goldberg AL; Mesirov JP; Root DE; Bhatia SN; Beroukhim R; Hahn WC
Cell; 2012 Aug; 150(4):842-54. PubMed ID: 22901813
[TBL] [Abstract][Full Text] [Related]
20. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
